Rapid Atrial Fibrillation Treatment Strategy

• Status: Unknown status
• Trial end date: 2020-09-15
• Target enrollment: 0
• Participant gender: All

Summary

Prospective, randomized, open-label clinical trial studying the treatment of new onset atrial fibrillation in critically ill patients with septic shock. Patients will be assigned to rhythm vs rate control strategies with various outcome measures assessed.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Our Lady of the Lake Regional Medical Center
• Treatments: Amiodarone; Calcium Channel Blockers

Criteria

Inclusion Criteria:

• No history of atrial fibrillation

• Meet Sepsis-3 criteria

• New onset atrial fibrillation in the ICU

• Atrial fibrillation treatment warranted

• Anticoagulation therapy not contraindicated

• On a ventilator

• Patient or family member willing to provide informed consent to participate in study

Exclusion Criteria:

• Post-cardiac or thoracic surgery

• Hemodynamically unstable

• Unable to tolerate anticoagulation

• Physician provider does not agree for patient to participate in study

• Patient or family member unwilling or unable to provide informed consent

• Expected death within 24 hours

• Non-English speakers